Home » Chinese Healthcare Investors »


|| Chinese investors acquired stake at Israeli biotech firm for $3 million

GuangxiWuzhou-IL.jpg
Guangxi Wuzhou Zhongheng Group, a Chinese investment holdings company, through its subsidiary has invested $3 million in Israeli biotechnology firm Integra Holdings.

Integra Holdings, founded in 2012, has a portfolio of companies operating in a variety of therapeutic areas such as oncology, Alzheimer's disease and infectious diseases. Integra Holdings has raised a total of $12 million to date.

Guangxi Wuzhou Zongheng Group is listed in the Chinese Investors Directory with the code XJO31

More details follows



Previous Post: Chinese investors acquired Melbourne Prince Hotel for $45 million
Next Post: CITIC Securities going to buy 60% of issued share from the retail Forex broker KVB Kunlun




|About Us

SinaBeat Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.



|Subscribe to mailing list

Enter your email address:



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2018     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on Google+  |   SinaBeat on LinkedIn